The European Commission is conducting a surprise inspection at the premises of a company active in the vaccine industry. The Commission is concerned that the company being inspected may have violated EU antitrust rules prohibiting the abuse of a dominant market position. In particular, the Commission is investigating exclusive practices that may constitute anti-competitive disparagement. Commission officials are accompanied by counterparts from the relevant national competition authorities